Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
Oei, E
Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association 09 2016 - e17-20 p. digital
Publication Type: Case Reports; Journal Article
1464-5491
10.1111/dme.12988 doi
Blood Glucose--metabolism
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1--complications
Diabetes Mellitus, Type 2--complications
Diabetic Nephropathies--etiology
Gliclazide--therapeutic use
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--therapeutic use
Incidence
Insulin--therapeutic use
Kidney Failure, Chronic--etiology
Male
Middle Aged
Monitoring, Ambulatory
Peritoneal Dialysis, Continuous Ambulatory
Pioglitazone
Thiazolidinediones--therapeutic use
Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association 09 2016 - e17-20 p. digital
Publication Type: Case Reports; Journal Article
1464-5491
10.1111/dme.12988 doi
Blood Glucose--metabolism
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1--complications
Diabetes Mellitus, Type 2--complications
Diabetic Nephropathies--etiology
Gliclazide--therapeutic use
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--therapeutic use
Incidence
Insulin--therapeutic use
Kidney Failure, Chronic--etiology
Male
Middle Aged
Monitoring, Ambulatory
Peritoneal Dialysis, Continuous Ambulatory
Pioglitazone
Thiazolidinediones--therapeutic use